- This event has passed.
VTE Dublin 2020
October 2, 2020
Diagnostic and therapeutic advances in venous thromboembolism (VTE)
Opening Address: Prof Fionnuala Ní Áinle, Consultant Haematologist, MMUH/Rotunda Hospitals
Session 1
| Time | Talk | Presenter | About the Presenter |
|---|---|---|---|
| 09:00-09:30 | Direct thrombus imaging: the future looks bright | Dr Erik Klok | Dept of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden, The Netherland; visiting Professor, Center for Thrombosis and Hemostasis, Mainz, Germany |
| 09:30-10:00 | Enoxaparin for Primary Thromboprophylaxis in Symptomatic Ambulatory Patients With COVID-19: the Randomized Controlled Trial OVID |
Dr Stefano Barco | Staff Physician, Clinic of Angiology, Zurich, Switzerland |
| 09:30-10:00 | HYPATIA: a randomised controlled trial in pregnant women with antiphospholipid antibodies | Dr Karen Schrieber | Danish Hospital for Rheumatic disease in Sonderburg, Denmark |
| 09:30-10:00 | Coffee | ||
| 09:30-10:00 | The Patient Experience | Ms Ann-Marie O’ Neill | Thrombosis Ireland |
Session 2
| Time | Talk | Presenter | About the Presenter |
|---|---|---|---|
| 11:30-12:00 | Covid-19 coagulopathy and thrombosis: Novel prognostic and therapeutic opportunities: The COCOON study | Dr Barry Kevane | Consultant Haematologist, Mater Misericordiae University Hospital, Dublin |
| 12:00-12:30 | VTE & Immunothrombosis; Where do we go from here? | Professor Beverley Jane Hunt OBE | Professor of Thrombosis & Haemostasis at King’s College London; Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP |
| 12:30-13:00 | COVID-19: clinical pitfalls in the ICU | Prof Jan Beyer Westendorf | Head of Division “Thrombosis Research”, Medical Clinic III Dresden University Clinic |
| 13:00-13:30 | Dr Clive Kearon Memorial Lecture Improving the diagnosis of pulmonary embolism in the emergency Department. |
Dr Kerstin de Wit | Assistant Professor, Division of Emergency Medicine, Department of Medicine; Emergency Medicine and Thrombosis Physician, Hamilton Health Science, Ontario, Canada |
| 13:30-14:00 | Lunch |
Session 3
| Time | Talk | Presenter | About the Presenter |
|---|---|---|---|
| 14.00-14:30 | Anticoagulation for COVID-19 | Dr Michelle Sholzberg | Division Head of Hematology-Oncology, Medical Director of the Coagulation Laboratory, Director of the Hematology-Oncology Clinical Research Group, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto |
| 14:30-15:00 | Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The COBRRA study | Dr. Lana Castellucci | Assistant Professor, Division of Hematology, Department of Medicine, University of Ottawa. Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute |
| 15:00-15:30 | The Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PARTUM) | Dr Leslie Skeith | Division of Hematology Department of Medicine, University of Calgary , Calgary, Canada, CanVECTOR Research Network |
| 15:30-16:00 | VTE in COVID-19: the Boston experience | Dr Rachel Rosovsky | Director, Thrombosis Research, Division of Hematology, Massachusetts General Hospital, Co-Chair of MGH’s Thrombosis Committee and Assistant Professor of Medicine, Harvard Medical School |
| 16:30-16:45 | Close |
This meeting is kindly supported by the Mater Postgraduate centre with unrestricted educational support from Leo Pharma, Sanofi, BMS and Bayer
